Huntington's Disease

Huntington's disease (HD) results from genetically programmed degeneration of brain cells, called neurons, in certain areas of the brain. This degeneration causes uncontrolled movements, loss of intellectual faculties, and emotional disturbance. HD is a familial disease, passed from parent to child through a mutation in the normal gene. Each child of an HD parent has a 50-50 chance of inheriting the HD gene. If a child does not inherit the HD gene, he or she will not develop the disease and cannot pass it to subsequent generations. A person who inherits the HD gene will sooner or later develop the disease. Whether one child inherits the gene has no bearing on whether others will or will not inherit the gene. Some early symptoms of HD are mood swings, depression, irritability or trouble driving, learning new things, remembering a fact, or making a decision. As the disease progresses, concentration on intellectual tasks becomes increasingly difficult and the patient may have difficulty feeding himself or herself and swallowing. The rate of disease progression and the age of onset vary from person to person. A genetic test, coupled with a complete medical history and neurological and laboratory tests, helps physicians diagnose HD. Presymptomic testing is available for individuals who are at risk for carrying the HD gene. In 1 to 3 percent of individuals with HD, no family history of HD can be found.
What is Huntington's Disease?

Huntington’s disease is an incurable neurodegenerative disease that affects muscle coordination and cognitive function. Symptoms of the disease usually start to develop around middle age. Huntington’s disease used to be called Huntington’s chorea because it is the most commonly inherited condition to lead to the involuntary movements referred to as chorea.

Read More

Overview

Feature Articles

Latest Huntington's Disease News and Research

Researchers develop first genetic maps for disease-linked DNA repeats

Researchers develop first genetic maps for disease-linked DNA repeats

New treatments in sight for challenging neuropsychiatric symptoms in neurodegenerative diseases

New treatments in sight for challenging neuropsychiatric symptoms in neurodegenerative diseases

Researchers find a promising approach to remove amyloid plaques in Alzheimer's disease

Researchers find a promising approach to remove amyloid plaques in Alzheimer's disease

Researchers identify new potential target for the treatment of Alzheimer's disease

Researchers identify new potential target for the treatment of Alzheimer's disease

Study shows cellular, molecular overlaps in ALS and FTLD

Study shows cellular, molecular overlaps in ALS and FTLD

Study provides insights into the action and specificity of splice-modifying drugs

Study provides insights into the action and specificity of splice-modifying drugs

UCLA Health study uncovers astrocytes' role in neuropsychiatric disorders

UCLA Health study uncovers astrocytes' role in neuropsychiatric disorders

Wastewater clues could revolutionize Alzheimer's detection

Wastewater clues could revolutionize Alzheimer's detection

Weill Cornell Medicine researcher wins $2.1 million grant to study repetitive DNA and RNA sequences

Weill Cornell Medicine researcher wins $2.1 million grant to study repetitive DNA and RNA sequences

Novel learning-based framework for predicting Alzheimer’s disease progression

Novel learning-based framework for predicting Alzheimer’s disease progression

Discovery of toxic and protective short RNAs associated with Alzheimer's disease and superior memory capacity

Discovery of toxic and protective short RNAs associated with Alzheimer's disease and superior memory capacity

SickKids scientists untangle cellular waste buildup in Zellweger Spectrum Disorder

SickKids scientists untangle cellular waste buildup in Zellweger Spectrum Disorder

Early-acting autophagy genes extend lifespan through alternative "garbage disposal" pathway in neurons

Early-acting autophagy genes extend lifespan through alternative "garbage disposal" pathway in neurons

Sex-specific brain immunometabolism differences may underlie increased Alzheimer's risk in women

Sex-specific brain immunometabolism differences may underlie increased Alzheimer's risk in women

C-Path releases new publication on transforming drug development for neurological disorders

C-Path releases new publication on transforming drug development for neurological disorders

UC Riverside scientists slow progression of Huntington's disease in flies and worms

UC Riverside scientists slow progression of Huntington's disease in flies and worms

Immune system proteins play role in early stages of Huntington's disease

Immune system proteins play role in early stages of Huntington's disease

Graphene oxide nanoflakes may help treat Alzheimer's disease

Graphene oxide nanoflakes may help treat Alzheimer's disease

The role of orexin in the modulation of sleep and wakefulness

The role of orexin in the modulation of sleep and wakefulness

Sleep dysfunction is underreported and underrecognized in Huntington's disease

Sleep dysfunction is underreported and underrecognized in Huntington's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.